The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
Official Title: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females
Study ID: NCT01381575
Brief Summary: This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.
Detailed Description:
Minimum Age: 9 Years
Eligible Ages: CHILD, ADULT
Sex: FEMALE
Healthy Volunteers: Yes
GSK Investigational Site, Coquitlam, British Columbia, Canada
GSK Investigational Site, Halifax, Nova Scotia, Canada
GSK Investigational Site, Sudbury, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Woodstock, Ontario, Canada
GSK Investigational Site, Sherbrooke, Quebec, Canada
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Kehl, Baden-Wuerttemberg, Germany
GSK Investigational Site, Schoenau Am Koenigssee, Bayern, Germany
GSK Investigational Site, Wuerzburg, Bayern, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Wolfenbuettel, Niedersachsen, Germany
GSK Investigational Site, Wolfsburg, Niedersachsen, Germany
GSK Investigational Site, Kleve-Materborn, Nordrhein-Westfalen, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Trier, Rheinland-Pfalz, Germany
GSK Investigational Site, Flensburg, Schleswig-Holstein, Germany
GSK Investigational Site, Weimar, Thueringen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Genova, Liguria, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Cuneo, Piemonte, Italy
GSK Investigational Site, Cagliari, Sardegna, Italy
GSK Investigational Site, Ragusa, Sicilia, Italy
GSK Investigational Site, Padova, Veneto, Italy
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taoyuan, , Taiwan
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Chiangmai, , Thailand
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR